Kalaris Therapeutics

KLRS
2.3605.60% ( -0.140 )
已收盘: 10月9日 16:00:00 (美东)

全部股东

股东类型

  • 风投/私募54.11%
  • 机构投资者16.19%
  • 公众及其他14.27%
  • 个人与内部人士6.02%
  • 其他9.41%

主要股东

主要股东 最新
股东
Samsara BioCapital LLC
54.11%1,288.12 万2.20%-6.69 万
RTW Investments, LP
5.46%130.00 万0.19%+0
ElevateBio, LLC
3.05%72.50 万0.11%+0
Alyeska Investment Group, L.P.
2.41%57.27 万0.09%+0
Samir PatelFormer Director & Co-Founder
2.22%52.83 万0.08%+0
Napoleone FerraraIndependent Director & Co-Founder
2.12%50.40 万0.07%+0
Vanguard Capital Management, LLC
1.95%46.49 万0.68%+17.28 万
Artal Group S.A.
1.83%43.58 万0.06%+0
Ikarian Capital, LLC
1.51%36.00 万0.05%+0
UBS Asset Management AG
1.10%26.21 万1.07%+25.59 万
Morana Jovan-EmbiricosFormer Independent Director
0.91%21.57 万0.03%+0
Renaissance Technologies LLC
0.63%14.94 万0.34%+8.32 万
Marshall Wace LLP
0.58%13.92 万0.29%+7.13 万
David HallalIndependent Chairman of the Board
0.55%13.06 万0.02%+0
Globeways Holdings II Limited
0.53%12.64 万0.02%+0
Geode Capital Management, LLC
0.48%11.40 万0.10%+2.65 万
Woodline Partners LP
0.42%10.00 万0.01%+0
ADAR1 Capital Management, LLC
0.42%10.00 万0.01%+0
Whi Trust Co Llc
0.41%9.75 万0.01%+0
Raymond James Financial, Inc.
0.41%9.72 万0.11%-2.17 万